The Acute Effects of Exercise on Breast Cancer Biomarkers (ACE Study) is enrolling women to test the effect of moderate intensity exercise on cancer risk factors such as biomarkers in healthy women. Knowing if exercise significantly alters these biomarkers, could help support guidelines for daily exercise for breast cancer prevention and could indicate that exercise even without weight loss is beneficial.
Contact: Jude Warner, acestudy@fredhutch.org
Researchers are studying a subtype of colorectal cancer (CRC) that develops via the serrated pathway with a goal of determining future prevention strategies and advancing treatment for CRC.
Funding Agency: National Institutes of Health
Contact: Rachel Malen, rmalen@fredhutch.org
Addressing research gaps in the molecular subtypes of breast cancer, we are taking a multidisciplinary approach to study the epidemiology and mutational landscapes of basal-like, luminal A, and luminal B tumors.
Funding Agency: DOD
Contact: Sarah Taylor, sataylor@fredhutch.org
Researchers are determining the cost-effectiveness of cord blood vs. haplo matched relatives using clinical information from the Bone Marrow Transplant (BMT) Clinical Trials Network (CTN) and insurance claims data.
Funding Agency: National Institutes of Health
Contact: Jordan Steelquist, jsteelq@fredhutch.org
Scientists identify differences in the bacterial community in tumors for patients with etiologically-distinct subgroups of colorectal cancer, and how those differences relate to survival.
Funding Agency: National Cancer Institute
Contact: Amanda Phipps, aphipps@fredhutch.org
Fred Hutchinson Cancer Center is conducting a study to learm more to improve the speed and accuracy of bacterial vaginosis diagnosis.
Contact: Sue Bartlett, sbartlett@fredhutch.org
Breast Cancer Initiative 2.5 is uniting the global breast cancer community behind a common goal to make breast health a global priority and reduce disparities in breast cancer outcomes for 2.5 million women by 2025.
After identifying early detection biomarkers for each of these cancers, we are conducting phase 2 and phase 3 validation studies directed towards clearly defined clinical applications.
Funding Agency: National Cancer Institute
Contact: Chris Li, cili@fredhutch.org
Researchers tested the efficacy and safety of beta-carotene and retinyl palmitate in people at high risk for lung cancer in a randomized, double-blind, placebo-controlled trial. Active follow-up of trial. participants ended on June of 2005; however, the program continues to support the extensive biological repository and ancillary studies that use CARET samples and data.
Funding Agency: National Cancer Institute
Contact: Jackie Dahlgren, jdahlgre@fredhutch.org
Using two ovarian cancer case-control studies, scientists are trying to determine why some women develop ovarian tumors and others do not.
Funding Agency: National Cancer Institute
Contact: Holly Harris, hharris@fredhutch.org